Comparison of the Transcriptomic Signatures of Skin and Lung Fibroblasts from Patients with Systemic Sclerosis
Fibrosis · 2026 · 4 (2) · 10008-10008
DOI: 10.70322/fibrosis.2026.10008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fibrosis, 2026. Verfasst von Samantha E Kotz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology and Immunology, MUSC, Charleston, SC 29425, USA. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Rheumatology and Immunology, MUSC, Charleston, SC 29425, USA.
Förderung
- NIAMS NIH HHS
Zitieren
APA
Kotz, S. E., Renaud, L., & Feghali-Bostwick, C. A. (2026). Comparison of the Transcriptomic Signatures of Skin and Lung Fibroblasts from Patients with Systemic Sclerosis. Fibrosis, 4(2), 10008-10008. https://doi.org/10.70322/fibrosis.2026.10008
Vancouver
Kotz SE, Renaud L, Feghali-Bostwick CA. Comparison of the Transcriptomic Signatures of Skin and Lung Fibroblasts from Patients with Systemic Sclerosis. Fibrosis. 2026;4(2):10008-10008. doi:10.70322/fibrosis.2026.10008
BibTeX
@article{Kotz2026,
author = {Kotz, Samantha E and Renaud, Ludivine and Feghali-Bostwick, Carol A},
title = {Comparison of the Transcriptomic Signatures of Skin and Lung Fibroblasts from Patients with Systemic Sclerosis},
journal = {Fibrosis},
year = {2026},
volume = {4},
number = {2},
pages = {10008--10008},
doi = {10.70322/fibrosis.2026.10008}
}
EUVIMED